''Mechanically-intelligent'' Intra-operative Tissue Assessment for Robot-Assisted Surgery (MIRAS)
''Mechanically-intelligent'' Intra-operative Tissue Assessment for Robot-Assisted Surgery (MIRAS)
批准号:
EP/V047612/1
负责人:
Yuhang Chen
金额:
$158.68万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
术中组织评估是微创手术的关键技术。外科医生需要识别不同的结构或病变区域,即使它们看起来可能都很相似。这项工作的目的是确定癌症手术中的切除边缘,以允许同时切除肿瘤和刚好足以确保完全切除癌症的边缘,但不会切除不必要的多余组织。目前,这样的手术边缘是使用外科医生的经验、手术前拍摄的各种图像以及外科医生在手术期间可以进行的任何视觉观察或在开放手术的情况下的触觉‘感觉’相结合来识别的。手术切缘的最终确认依赖于术后的组织病理学,切除的组织是通过显微镜进行评估的。只有到那时,才能知道手术是否成功,或者是否需要进一步手术和/或更积极的术后治疗。这些挑战在外科手术切除直肠和一些盆腔器官的肿瘤方面尤其严峻,因为更广泛的手术切除受到与具有高度功能重要性的解剖结构的密切联系的限制,例如,供应膀胱、肠道、性器官和下肢的神经和血管。微创技术的发展(如腹腔镜术或沿着身体导管的手术,如直肠或结肠)已经消除了外科手术对组织特征的‘感觉’,包括对手术边缘的评估。这凸显了临床上对定量、稳健、可靠和循证的方法的需求尚未得到满足,该方法可以确定最佳手术范围并向外科医生提供反馈,以便在手术过程中做出决定。机器人辅助手术(RAS)是微创外科的下一个发展方向,在治疗各种疾病方面取得了快速发展。它通过让外科医生更好地控制仪器并提供3D可视化等功能来提高临床准确性。这样的发展在骨盆和直肠等受限空间特别有用。到目前为止,RAS在肿瘤外科中的应用有限,主要是因为目前的RAS系统几乎完全依赖于视觉反馈,不能为临床决策提供支持。这项工作旨在为RAS提供一种新的功能,以提高术中的临床决策能力。这项技术将加速RAS在许多类型的内脏和实体器官手术中的发展,在这些手术中,视觉反馈有限或不足以可靠地确定手术边缘。这一合作伙伴关系将4个具有两个临床专长的不同和互补的工程小组聚集在一起,并得到两个行业的支持,一个是医疗传感器领域的中小企业,另一个是外科机器人制造商。该小组将专注于两个主要目标:1.设计一种可通过标准微创手术器械展开的微型探头,能够在手术中对组织表面进行机械测量。2.建立数据模型方法,以便处理实时测量数据,以产生对手术边缘的定量评估,作为手术中对外科医生的反馈。该方法将分阶段进行一系列试验,包括体外人体组织和活体动物模型,最后在手术环境中进行演示。通过这项工作,该合作伙伴关系预计将开发一种独特的、面向未来的“RAS制造更智能”技术,用于术中肿瘤和肿瘤边缘的识别,进而应用于其他外科领域。
英文摘要
Intra-operational tissue assessment is a key enabling technology for minimally invasive surgery. Surgeons operating along a "keyhole" or similar means of access for minimally invasive surgery need to identify different structures or diseased areas, even when these all may look similar. This work is aimed at identifying the resection margin in cancer surgery, to allow the removal of a tumour together with a margin which is just enough to ensure complete cancer excision, but without unnecessary excess tissue removal. Currently, such a surgical margin is identified using a combination of the surgeon's experience, images of various kinds taken prior to the operation coupled with any visual observations, or tactile 'feel' in the scenario of open surgery, that the surgeon can make during the operation. Ultimate confirmation of the surgical margin relies on post-operative histopathology, where the removed tissue is assessed microscopically. Only then, will it be known if the removal has been successful or if further surgery and/or more aggressive post-operative treatment is required. These challenges are particularly acute in surgical removal of tumours from the rectum and some pelvic organs, where wider surgical excision is constrained by close proximity of anatomical structures with high functional importance, e.g. nerves and vasculature supplying bladder, bowel, sexual organs and lower limbs. The development of minimally invasive techniques (such as laparoscopy or operations along body ducts, such as in the rectum or colon) have removed surgical 'feel' for tissue characteristics, including assessment of surgical margin. This highlights an unmet clinical need for a quantitative, robust, reliable and evidence-based method of determining the optimal surgical margin and providing feedback to the surgeon in a way that it can be used to make decisions during the operation.Robot-Assisted Surgery (RAS) is the next development in minimally invasive surgery and has seen rapid development in treatment of a wide variety of conditions. It offers improved clinical accuracy by giving surgeons better control of instruments and providing features such as 3D visualisation. Such developments are particularly useful in confined spaces such as the pelvis and rectum. So far, RAS has found limited application in oncological surgery, mostly because current RAS systems rely almost entirely on visual feedback, and do not provide support for clinical decision making. This work aims to provide a novel function in RAS to enhance intra-operative clinical decision making. This technology would accelerate development of RAS in many types of visceral and solid-organ surgery where visual feedback is limited or inadequate to determine surgical margins reliably.This partnership brings together 4 distinct and complementary engineering groups with two clinical specialisms and is supported by two industries, an SME in the medical sensors area and a manufacturer of surgical robots. The group will focus on two principal aims: 1. to devise a microfabricated probe deployable via a standard minimally invasive surgery instrument capable of making intra-operative mechanical measurements on the tissue surface. 2. to establish data modelling methods in order to process the real-time measurement data to produce quantitative assessment of surgical margin as intra-operative feedback to the surgeon.The approach will be developed in a staged series of trials, including on ex vivo human tissue and in vivo animal models, with ultimate demonstration in a surgical environment. Through the work, the partnership expects to develop a unique and future-proof 'RAS-made-smarter' technology for applications in intra-operative identification of tumours and tumour margins and, by extension, in other surgical areas.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1002/cnm.3758
发表时间:
2023-07-21
期刊:
INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING
影响因子:
2.1
作者:
[Anderson,Calum, Ntala,Chara, Chen,Yuhang]
通讯作者:
Chen,Yuhang
Design Optimisation of Tissue Scaffolds Using Patient-specific and In Vivo Criteria
-
批准号:EP/N006089/1
-
项目类别:Research Grant
-
资助金额:$12.71万
-
财政年份:2016
-
负责人:Yuhang Chen
-
依托单位:
国内基金
海外基金
Intelligent Patent Analysis for Optimized Technology Stack Selection:Blockchain BusinessRegistry Case Demonstration
-
批准号:--
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:USHARANI HAREESH GOVINDARA JAN
-
依托单位: